Lignomak 5% Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Lidocaine (5%)
Overview Lignomak 5% Injection
Lignomak 5% Injection provides localized anesthesia, suitable for minor surgical interventions including dental, oral, and other diagnostic or therapeutic procedures. Administration should be exclusively by qualified medical personnel. Its mechanism involves temporarily blocking pain signals to the brain, ensuring a comfortable procedure. Generally well-tolerated, it may cause mild, transient injection site reactions like redness, swelling, or soreness in some patients. Prolonged numbness or other adverse effects necessitate immediate consultation with a physician. Pre-treatment disclosure of any pre-existing cardiac conditions or concurrent use of cardiac medications is crucial. Pregnant or breastfeeding individuals should seek medical guidance before use. Due to potential dizziness, avoid driving or operating machinery following administration.
Primary Ingredients of Lignomak 5% Injection
There is no text provided to rephrase.
Uses of Lignomak 5% Injection
Regional numbing achieved via localized anesthetic administration.
Major Benefits of Lignomak 5% Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Lignomak 5% Injection:
- Injection site reactions (pain, swelling, redness)
How to use Lignomak 5% Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Lignomak 5% Injection works:
Lignomak 5% Injection provides localized pain relief. Its mechanism of action involves interrupting nerve impulse transmission, preventing pain signals from reaching the brain and thus reducing pain perception.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Lignomak 5% Injection concurrently with alcohol. Seek medical advice.
PregnancySAFE IF PRESCRIBED
Lignomak 5% Injection is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harm to offspring; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Lignomak 5% Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant exposure.
DrivingSAFE
Driving ability is typically unaffected by Lignomak 5% Injection.
KidneyCAUTION
For individuals with severe kidney impairment, administering Lignomak 5% Injection requires careful consideration. A modified dosage of Lignomak 5% Injection may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of Lignomak 5% Injection requires careful monitoring. Dosage modification of Lignomak 5% Injection might be necessary. Physician consultation is advised.
What if you forget to take Lignomak 5% Injection :
NA
Facts to Know About Lignomak 5% Injection
| Label | Value |
|---|---|
| Chemical Type | Amide-based compound |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Action Class | Amide local anesthetics |
3,018 People bought this recently